Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 44 (D.Del. Jul. 19, 2019)
Attorneys for University of Massachusetts and Carmel Laboratories, LLC
Cite Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 44 (D.Del. Jul. 19, 2019)
+ More Snippets
Document
IPR2018-00778, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Mar. 21, 2018)
For more information, please consult the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012), which is available on the Board Web site at http://www.uspto.gov/PTAB.
Patent Owner is advised of the requirement to submit mandatory notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of the petition.
The parties are advised that under 37 C.F.R. § 42.10(c), recognition of counsel pro hac vice requires a showing of good cause.
Many non-profit organizations, both inside and outside the intellectual property field, offer alternative dispute resolution services.
If the parties actually engage in alternative dispute resolution, the PTAB would be interested to learn what mechanism (e.g., arbitration, mediation, etc.) was used and the general result.
Cite Document
IPR2018-00778, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Mar. 21, 2018)
+ More Snippets
Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 43 (D.Del. Jul. 15, 2019)
Attorneys for University of Massachusetts and Carmel Laboratories, LLC DATED: July 15, 2019
Attorneys for Carmel Laboratories, LLC Attorney for University of Massachusetts
Cite Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 43 (D.Del. Jul. 15, 2019)
+ More Snippets
Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 42 (D.Del. Jul. 15, 2019)
Cite Document
University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 42 (D.Del. Jul. 15, 2019)
+ More Snippets
Document
University of Massachusetts et al v. L'Oral U.S.A., Inc., 1:17-cv-00868, No. 37 (D.Del. May. 30, 2019)
Motion to Extend Time
UNIVERSITY OF MASSACHUSETTS and
IT IS HEREBY STIPULATED AND AGREED, by and between Plaintiffs and L’Oréal USA, Inc., through their undersigned counsel and subject to the approval of the Court, that the deadline for L’Oréal USA, Inc. to move, answer or otherwise respond to the complaint is hereby extended through and including June 14, 2019.
SO ORDERED this ________ day of ___________, 2019.
United States Magistrate Judge
Cite Document
University of Massachusetts et al v. L'Oral U.S.A., Inc., 1:17-cv-00868, No. 37 (D.Del. May. 30, 2019)
+ More Snippets
Document
University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 23 (D.Del. Oct. 16, 2017)
Motion to Dismiss for Lack of Jurisdiction
MEDICAL SCHOOL and CARMEL
Defendant L’Oréal S.A. (“L’Oréal S.A.”), by and through its undersigned counsel, hereby moves to dismiss the First Amended Complaint (D.I.
13) pursuant to Federal Rule of Civil Procedure (“Rule”) Rule 12(b)(2), for lack of personal jurisdiction, and Rule 12(b)(6), for failure to state a claim upon which relief can be granted (the “Motion”).
The grounds for this Motion are set forth fully in L’Oréal S.A.’s Opening Brief filed contemporaneously herewith, as well as the Declaration of Roy Rabinowitz.
Cite Document
University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 23 (D.Del. Oct. 16, 2017)
+ More Snippets
Document
University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 13 (D.Del. Aug. 18, 2017)
Complaint
Dr. James G. Dobson, Jr., a renowned cardiovascular physiologist and the former Chairman of the Department of Physiology at the University of Massachusetts Medical School, has been conducting research on adenosine since approximately the mid 1960’s.
Easeamine was initially released in 2009 and, due to its innovative and unique properties, received favorable press in newspapers around the world, leading to significant sales in its first year.
Based on the strength of initial sales, Carmel Labs reinvested substantial sums— obtained in part by leveraging property owned by the monastery—to expand the Easeamine line.
Carmel Labs retained experienced cosmetic industry professionals as well as a contract manufacturer and a branding and public relations firm to assist in creating and marketing a full Easeamine product line, with an anticipated release date in fall of 2010.
Due to public focus on Defendants’ adenosine products, projected sales of Easeamine did not materialize, resulting in lost revenue to Carmel Labs, and ultimately, to Teresian Carmelites.
Cite Document
University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 13 (D.Del. Aug. 18, 2017)
+ More Snippets
Document
IPR2018-00778, No. 6 Motion - Patent Owners Unopposed Motion For District Court Type Claim Construction In Accordance With 37 CFR Section 41100b (P.T.A.B. Apr. 27, 2018)
Cite Document
IPR2018-00778, No. 6 Motion - Patent Owners Unopposed Motion For District Court Type Claim Construction In Accordance With 37 CFR Section 41100b (P.T.A.B. Apr. 27, 2018)
+ More Snippets
Document
IPR2018-00778, No. 13 Refund Request - Petitioners Request for Refund for Non Instituted Case (P.T.A.B. Dec. 17, 2018)
Cite Document
IPR2018-00778, No. 13 Refund Request - Petitioners Request for Refund for Non Instituted Case (P.T.A.B. Dec. 17, 2018)
+ More Snippets
Document
IPR2018-00778, No. 2 Petition - PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,423,327 (P.T.A.B. Mar. 15, 2018)
Cite Document
IPR2018-00778, No. 2 Petition - PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,423,327 (P.T.A.B. Mar. 15, 2018)
+ More Snippets
Document
IPR2018-00778, No. 11 Rehearing Request in re Petition Institution Decision Denied - PETITIONERS CORRECTED REQUEST FOR REHEARING (P.T.A.B. Oct. 11, 2018)
Cite Document
IPR2018-00778, No. 11 Rehearing Request in re Petition Institution Decision Denied - PETITIONERS CORRECTED REQUEST FOR REHEARING (P.T.A.B. Oct. 11, 2018)
+ More Snippets
Document
IPR2018-00778, No. 10 Rehearing Request in re Petition Institution Decision Denied - PETITIONER¿¿¿S REQUEST FOR REHEARING (P.T.A.B. Oct. 9, 2018)
Cite Document
IPR2018-00778, No. 10 Rehearing Request in re Petition Institution Decision Denied - PETITIONER¿¿¿S REQUEST FOR REHEARING (P.T.A.B. Oct. 9, 2018)
+ More Snippets
Document
IPR2018-00778, No. 8 Mandatory Notice - Patent Owner Updated Mandatory Notices Under 37 CFR Section 428 (P.T.A.B. Jul. 30, 2018)
Cite Document
IPR2018-00778, No. 8 Mandatory Notice - Patent Owner Updated Mandatory Notices Under 37 CFR Section 428 (P.T.A.B. Jul. 30, 2018)
+ More Snippets
Document
IPR2018-00778, No. 7 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Jun. 21, 2018)
Cite Document
IPR2018-00778, No. 7 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Jun. 21, 2018)
+ More Snippets
Document
IPR2018-00778, No. 4 Power of Attorney - Patent Owner Power of Attorney (P.T.A.B. Apr. 5, 2018)
Cite Document
IPR2018-00778, No. 4 Power of Attorney - Patent Owner Power of Attorney (P.T.A.B. Apr. 5, 2018)
+ More Snippets